ArticleAlpha psychiatry2025
Effects of Intermittent Fasting on Anxiety and the Functional Connectivity of the Amygdala in Healthy Adults.
Article in Alpha psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nutritional timing and stress biology: intermittent fasting as a hormetic signal for adaptation.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study assessed the effect of intermittent fasting on anxiety, depression, and connectivity of the amygdala by functional magnetic resonance imaging in healthy adults. The findings could provide insights into IF as a potential non-pharmacological intervention for anxiety, offering clinical significance as a cost-effective and accessible alternative or adjunct therapy. Methods: Twenty-six healthy adults followed a time-restricted eating regimen for 50 days, fasting for 18 hours daily. Assessments were conducted at baseline, during fasting (days 10, 30, and 50), and after fasting (days 20 and ~60). Measurements included body mass index (BMI), metabolic parameters, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and resting-state functional magnetic resonance imaging (fMRI) connectivity of the amygdala. Results: The BMI, glucose and insulin concentrations, insulin resistance, and anxiety scores significantly decreased during and after fasting compared to the baseline measurements (all Conclusion: IF reduces anxiety by modulating amygdala functional connectivity and enhancing brain plasticity, suggesting its potential as a therapeutic approach for anxiety and related emotional disorders. The findings underscore IF's promise as an alternative or adjuvant intervention in psychiatric care. Clinical Trial Registration: The study was registered at Clinicaltrials.gov (https://www.chictr.org.cn/showproj.html?proj=136213), registration number: ChiCTR2100052473.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.